Updates to the Drug Benefit List

First Page		Document Content
Date: 2013-06-24 13:31:42 Dosage forms Angiotensin II receptor antagonists Carboxylic acids Tetrazoles Pharmaceutical industry Valsartan Hydrochlorothiazide OROS Mylan Chemistry Organic chemistry Pharmacology		Updates to the Drug Benefit List Add to Reading List Source URL: hc-sc.gc.ca Download Document from Source Website File Size: 731,81 KB Share Document on Facebook

	Mylan Agrees to Pay $465 Million in Restitution to Resolve False Claims Allegations The National Association of Medicaid Fraud Control units announced on August 17, 2017 that an agreement has been reached to settle alleg DocID: 1uUDJ - View Document
	Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills WILSON SONSINI GOODRICH & ROSATI DocID: 1trJa - View Document
	IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD MYLAN PHARMACEUTICALS INC., Petitioner v. SHIRE LABORATORIES, INC., DocID: 1tqnl - View Document
	Paper No. ____ Filed: November 22, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee () Michael T. Rosato () Jad A. Mills () DocID: 1tpON - View Document
	Paper No. ____ Filed: May 25, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills DocID: 1tkI9 - View Document